ISTO Technologies Announces Participation in OneMedForum NY 2012
July 09, 2012 15:01 ET
|
ISTO
ST. LOUIS, July 9, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., a privately-held orthobiologics company, announced today that Mitchell Seyedin, Ph. D., President and Chief Executive Officer, is...
ISTO Technologies, Inc. Announces Fundamental U.S. Patent Issuance for InQu(R) Product Line
June 05, 2012 08:30 ET
|
ISTO
ST. LOUIS, June 5, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., a leading orthobiologics company focused on developing breakthrough products to regenerate and restore function to damaged...
ISTO Technologies Announces Participation in the Regenerative Medicine Insight Track at the Biotech Showcase
January 06, 2012 12:49 ET
|
ISTO
ST. LOUIS, Jan. 6, 2012 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., today announced that Scott Gill, Chief Financial Officer, will be participating in a panel session at the Regenerative Medicine...
ISTO Technologies Receives CE Mark for InQu(R) Bone Graft Substitute and Extender
October 13, 2011 08:00 ET
|
ISTO
ST. LOUIS, Mo., Oct. 13, 2011 (GLOBE NEWSWIRE) -- ISTO Technologies, Inc., an orthobiologics company developing innovative cartilage and bone products for spinal therapy and sports medicine...